{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:55:53Z","timestamp":1793325353044,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2202-15-109","type":"journal-article","created":{"date-parts":[[2014,9,21]],"date-time":"2014-09-21T23:01:13Z","timestamp":1411340473000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Differential sleep-promoting effects of dual orexin receptor antagonists and GABAAreceptor modulators"],"prefix":"10.1186","volume":"15","author":[{"given":"Anthony L","family":"Gotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L","family":"Garson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina L","family":"Munden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven V","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela L","family":"Tannenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Kuduk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrence","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M","family":"Uslaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer J","family":"Tye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Winrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Renger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,22]]},"reference":[{"key":"3800_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1176\/appi.ps.56.3.332","volume":"56","author":"RM Benca","year":"2005","unstructured":"Benca RM: Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv. 2005, 56: 332-343. 10.1176\/appi.ps.56.3.332.","journal-title":"Psychiatr Serv"},{"key":"3800_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s13311-012-0148-3","volume":"9","author":"T Roeh","year":"2012","unstructured":"Roeh T, Roth T: Insomnia pharmacotherapy. Neurotherapeutics. 2012, 9: 728-738. 10.1007\/s13311-012-0148-3.","journal-title":"Neurotherapeutics"},{"key":"3800_CR3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5664\/jcsm.27286","volume":"4","author":"S Schutte-Rodin","year":"2008","unstructured":"Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M: Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008, 4: 487-504.","journal-title":"J Clin Sleep Med"},{"key":"3800_CR4","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1177\/0269881110379307","volume":"24","author":"SJ Wilson","year":"2010","unstructured":"Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG: British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010, 24: 1577-1601. 10.1177\/0269881110379307.","journal-title":"J Psychopharmacol"},{"key":"3800_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","volume":"51","author":"TE Scammell","year":"2011","unstructured":"Scammell TE, Winrow CJ: Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol. 2011, 51: 243-266. 10.1146\/annurev-pharmtox-010510-100528.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3800_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/bph.12261","volume":"171","author":"CJ Winrow","year":"2014","unstructured":"Winrow CJ, Renger JJ: Discovery and development of orexin receptor antagonists as therapeutics for insomnia. Br J Pharmacol. 2014, 171: 283-293. 10.1111\/bph.12261.","journal-title":"Br J Pharmacol"},{"key":"3800_CR7","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1523\/JNEUROSCI.1887-05.2005","volume":"25","author":"MG Lee","year":"2005","unstructured":"Lee MG, Hassani OK, Jones BE: Discharge of identified orexin\/hypocretin neurons across the sleep-waking cycle. J Neurosci. 2005, 25: 6716-6720. 10.1523\/JNEUROSCI.1887-05.2005.","journal-title":"J Neurosci"},{"key":"3800_CR8","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS: Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998, 18: 9996-10015.","journal-title":"J Neurosci"},{"key":"3800_CR9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.5665\/sleep.1996","volume":"35","author":"P Bettica","year":"2012","unstructured":"Bettica P, Squassante L, Zamuner S, Nucci G, Danker-Hopfe H, Ratti E: The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia. Sleep. 2012, 35: 1097-1104.","journal-title":"Sleep"},{"key":"3800_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/nm1544","volume":"13","author":"C Brisbare-Roch","year":"2007","unstructured":"Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S, Mueller C, Nayler O, van Gerven J, de Haas SL, Hess P, Qiu CB, Buchmann S, Scherz M, Weller T, Fischli W, Clozel M, Jenck F: Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med. 2007, 13: 150-155. 10.1038\/nm1544.","journal-title":"Nat Med"},{"key":"3800_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3109\/01677063.2011.566953","volume":"25","author":"CJ Winrow","year":"2011","unstructured":"Winrow CJ, Gotter AL, Cox CD, Doran SM, Tannenbaum PL, Breslin MJ, Garson SL, Fox SV, Harrell CM, Stevens J, Reiss DR, Cui D, Coleman PJ, Renger JJ: Promotion of sleep by suvorexant - a novel dual orexin receptor antagonist. J Neurogenet. 2011, 25: 52-61. 10.3109\/01677063.2011.566953.","journal-title":"J Neurogenet"},{"key":"3800_CR12","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.neuropharm.2011.10.003","volume":"62","author":"CJ Winrow","year":"2012","unstructured":"Winrow CJ, Gotter AL, Cox CD, Tannenbaum PL, Garson SL, Doran SM, Breslin MJ, Schreier JD, Fox SV, Harrell CM, Stevens J, Reiss DR, Cui D, Coleman PJ, Renger JJ: Pharmacological characterization of MK-6096 - a dual orexin receptor antagonist for insomnia. Neuropharmacology. 2012, 62: 978-987. 10.1016\/j.neuropharm.2011.10.003.","journal-title":"Neuropharmacology"},{"key":"3800_CR13","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1038\/npp.2013.139","volume":"38","author":"SV Fox","year":"2013","unstructured":"Fox SV, Gotter AL, Tye SJ, Garson SL, Savitz AT, Uslaner JM, Brunner JI, Tannenbaum PL, McDonald TP, Hodgson R, Yao L, Bowlby MR, Kuduk SD, Coleman PJ, Hargreaves R, Winrow CJ, Renger JJ: Quantitative electroencephalography within sleep\/wake states differentiates GABA-A modulators eszopiclone and zolpidem from dual orexin receptor antagonists in rats. Neuropsychopharmacology. 2013, 38: 2401-2408. 10.1038\/npp.2013.139.","journal-title":"Neuropsychopharmacology"},{"key":"3800_CR14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/npp.2011.310","volume":"37","author":"P Bettica","year":"2012","unstructured":"Bettica P, Squassante L, Groeger JA, Gennery B, Winsky-Sommerer R, Dijk DJ: Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia. Neuropsychopharmacology. 2012, 37: 1224-1233. 10.1038\/npp.2011.310.","journal-title":"Neuropsychopharmacology"},{"key":"3800_CR15","first-page":"259","volume":"36","author":"H Sun","year":"2013","unstructured":"Sun H, Kennedy WP, Wilbraham D, Lewis N, Calder N, Li X, Ma J, Yee KL, Ermlich S, Mangin E, Lines C, Rosen L, Chodakewitz J, Murphy GM: Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep. 2013, 36: 259-267.","journal-title":"Sleep"},{"key":"3800_CR16","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","volume":"79","author":"WJ Herring","year":"2012","unstructured":"Herring WJ, Snyder E, Budd K, Hutzelmann J, Snavely D, Liu K, Lines C, Roth T, Michelson D: Orexin receptor antagonism for treatment of insomnia: A randomized clinical trial of suvorexant. Neurology. 2012, 79: 2265-2274. 10.1212\/WNL.0b013e31827688ee.","journal-title":"Neurology"},{"key":"3800_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","volume":"13","author":"D Michelson","year":"2014","unstructured":"Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, Walsh JK, Krystal AD, Benca RM, Cohn M, Lines C, Roth T, Herring WJ: Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014, 13: 461-471. 10.1016\/S1474-4422(14)70053-5.","journal-title":"Lancet Neurol"},{"key":"3800_CR18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/sleep\/25.1.18","volume":"25","author":"A Rechtschaffen","year":"2002","unstructured":"Rechtschaffen A, Bergmann BM: Sleep deprivation in the rat: an update of the 1989 paper. Sleep. 2002, 25: 18-24.","journal-title":"Sleep"},{"key":"3800_CR19","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1101\/lm.84805","volume":"12","author":"TE Bjorness","year":"2005","unstructured":"Bjorness TE, Riley BT, Tysor MK, Poe GR: REM restriction persistently alters strategy used to solve a spatial task. Learn Mem. 2005, 12: 352-359. 10.1101\/lm.84805.","journal-title":"Learn Mem"},{"key":"3800_CR20","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1523\/JNEUROSCI.23-29-09687.2003","volume":"23","author":"CM McDermott","year":"2003","unstructured":"McDermott CM, LaHoste GJ, Chen C, Musto A, Bazan NG, Magee JC: Sleep deprivation causes behavioral, synaptic, and membrane excitability alterations in hippocampal neurons. J Neurosci. 2003, 23: 9687-9695.","journal-title":"J Neurosci"},{"key":"3800_CR21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5664\/jcsm.26918","volume":"3","author":"S Banks","year":"2007","unstructured":"Banks S, Dinges DF: Behavioral and physiological consequences of sleep restriction. J Clin Sleep Med. 2007, 3: 519-528.","journal-title":"J Clin Sleep Med"},{"key":"3800_CR22","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.conb.2013.02.008","volume":"23","author":"M Basner","year":"2013","unstructured":"Basner M, Rao H, Goel N, Dinges DF: Sleep deprivation and neurobehavioral dynamics. Curr Opin Neurobiol. 2013, 23: 854-863. 10.1016\/j.conb.2013.02.008.","journal-title":"Curr Opin Neurobiol"},{"key":"3800_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.8036518","volume":"265","author":"A Karni","year":"1994","unstructured":"Karni A, Tanne D, Rubenstein BS, Askenasy JJ, Sagi D: Dependence on REM sleep of overnight improvement of a perceptual skill. Science. 1994, 265: 679-682. 10.1126\/science.8036518.","journal-title":"Science"},{"key":"3800_CR24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/sleep\/29.2.145","volume":"29","author":"T Roeh","year":"2006","unstructured":"Roeh T, Hyde M, Blaisdell B, Greenwald M, Roth T: Sleep loss and REM sleep loss are hyperalgesic. Sleep. 2006, 29: 145-151.","journal-title":"Sleep"},{"key":"3800_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fnbeh.2014.00182","volume":"8","author":"PL Tannenbaum","year":"2014","unstructured":"Tannenbaum PL, Stevens J, Binns J, Savitz AT, Garson SL, Fox SV, Coleman P, Kuduk SD, Gotter AL, Marino M, Tye SJ, Uslaner JM, Winrow CJ, Renger JJ: Orexin receptor antagonist-induced sleep does not impair the ability to wake in response to emotionally salient acoustic stimuli in dogs. Front Behav Neurosci. 2014, 8: 182.","journal-title":"Front Behav Neurosci"},{"key":"3800_CR26","first-page":"559","volume":"37","author":"S Bertini","year":"1995","unstructured":"Bertini S, Buronfosse F, Pineau X, Berny P, Lorgue G: Benzodiazepine poisoning in companion animals. Vet Hum Toxicol. 1995, 37: 559-562.","journal-title":"Vet Hum Toxicol"},{"key":"3800_CR27","first-page":"208","volume":"16","author":"JA Richardson","year":"2002","unstructured":"Richardson JA, Gwaltney-Brant SM, Albretsen JC, Khan SA, Porter JA: Clinical syndrome associated with zolpidem ingestion in dogs: 33 cases (January 1998-July 2000). J Vet Intern Med. 2002, 16: 208-210.","journal-title":"J Vet Intern Med"},{"key":"3800_CR28","first-page":"22","volume":"44","author":"TA Wismer","year":"2002","unstructured":"Wismer TA: Accidental ingestion of alprazolam in 415 dogs. Vet Hum Toxicol. 2002, 44: 22-23.","journal-title":"Vet Hum Toxicol"},{"key":"3800_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0361-9230(94)90018-3","volume":"34","author":"GP Nunes Junior","year":"1994","unstructured":"Nunes Junior GP, Tufik S, Nobrega JN: Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation. Brain Res Bull. 1994, 34: 453-456. 10.1016\/0361-9230(94)90018-3.","journal-title":"Brain Res Bull"},{"key":"3800_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuroscience.2007.05.029","volume":"148","author":"S Zhang","year":"2007","unstructured":"Zhang S, Lin L, Kaur S, Thankachan S, Blanco-Centurion C, Yanagisawa M, Mignot E, Shiromani PJ: The development of hypocretin (orexin) deficiency in hypocretin\/ataxin-3 transgenic rats. Neuroscience. 2007, 148: 34-43. 10.1016\/j.neuroscience.2007.05.029.","journal-title":"Neuroscience"},{"key":"3800_CR31","volume-title":"Sleep","author":"J Ma","year":"2014","unstructured":"Ma J, Svetnik V, Snyder E, Lines C, Roth T, Herring WJ: Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects. Sleep. 2014, 37: http:\/\/www.journalsleep.org\/AcceptedPapers\/SP-716-13.pdf."},{"key":"3800_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3389\/fnins.2013.00235","volume":"7","author":"D Hoyer","year":"2013","unstructured":"Hoyer D, Durst T, Fendt M, Jacobson LH, Betschart C, Hintermann S, Behnke D, Cotesta S, Laue G, Ofner S, Legangneux E, Gee CE: Distinct effects of IPSU and suvorexant on mouse sleep architecture. Front Neurosci. 2013, 7: 235.","journal-title":"Front Neurosci"},{"key":"3800_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fnins.2014.00028","volume":"8","author":"C Dugovic","year":"2014","unstructured":"Dugovic C, Shelton JE, Yun S, Bonaventure P, Shireman BT, Lovenberg TW: Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism. Front Neurosci. 2014, 8: 28.","journal-title":"Front Neurosci"},{"key":"3800_CR34","first-page":"22","volume":"12","author":"CA Kushida","year":"1989","unstructured":"Kushida CA, Bergmann BM, Rechtschaffen A: Sleep deprivation in the rat: IV. Paradoxical Sleep Deprivation Sleep. 1989, 12: 22-30.","journal-title":"Paradoxical Sleep Deprivation Sleep"},{"key":"3800_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0166-4328(95)00020-T","volume":"69","author":"A Rechtschaffen","year":"1995","unstructured":"Rechtschaffen A, Bergmann BM: Sleep deprivation in the rat by the disk-over-water method. Behav Brain Res. 1995, 69: 55-63. 10.1016\/0166-4328(95)00020-T.","journal-title":"Behav Brain Res"},{"key":"3800_CR36","doi-asserted-by":"publisher","first-page":"e47042","DOI":"10.1371\/journal.pone.0047042","volume":"7","author":"T Kumar","year":"2012","unstructured":"Kumar T, Jha SK: Sleep deprivation impairs consolidation of cued fear memory in rats. PLoS One. 2012, 7: e47042-10.1371\/journal.pone.0047042.","journal-title":"PLoS One"},{"key":"3800_CR37","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/nature08488","volume":"461","author":"CG Vecsey","year":"2009","unstructured":"Vecsey CG, Baillie GS, Jaganath D, Havekes R, Daniels A, Wimmer M, Huang T, Brown KM, Li XY, Descalzi G, Kim SS, Chen T, Shang YZ, Zhuo M, Houslay MD, Abel T: Sleep deprivation impairs cAMP signalling in the hippocampus. Nature. 2009, 461: 1122-1125. 10.1038\/nature08488.","journal-title":"Nature"},{"key":"3800_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0031-9384(96)00363-0","volume":"61","author":"BD Youngblood","year":"1997","unstructured":"Youngblood BD, Zhou J, Smagin GN, Ryan DH, Harris RB: Sleep deprivation by the \"flower pot\" technique and spatial reference memory. Physiol Behav. 1997, 61: 249-256. 10.1016\/S0031-9384(96)00363-0.","journal-title":"Physiol Behav"},{"key":"3800_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5664\/jcsm.3352","volume":"10","author":"JM Hall-Porter","year":"2014","unstructured":"Hall-Porter JM, Schweitzer PK, Eisenstein RD, Ahmed HA, Walsh JK: The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation. J Clin Sleep Med. 2014, 10: 27-34.","journal-title":"J Clin Sleep Med"},{"key":"3800_CR40","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/nature04284","volume":"437","author":"CB Saper","year":"2005","unstructured":"Saper CB, Scammell TE, Lu J: Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005, 437: 1257-1263. 10.1038\/nature04284.","journal-title":"Nature"},{"key":"3800_CR41","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1177\/0269881109106927","volume":"24","author":"DJ Nutt","year":"2010","unstructured":"Nutt DJ, Stahl SM: Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol. 2010, 24: 1601-1612. 10.1177\/0269881109106927.","journal-title":"J Psychopharmacol"},{"key":"3800_CR42","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2174\/1568026023393507","volume":"2","author":"W Sieghart","year":"2002","unstructured":"Sieghart W, Sperk G: Subunit composition, distribution and function of GABA-A receptor subtypes. Curr Top Med Chem. 2002, 2: 795-816. 10.2174\/1568026023393507.","journal-title":"Curr Top Med Chem"},{"key":"3800_CR43","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M: Benzodiazepines revisited\u2013will we ever learn?. Addiction. 2011, 106: 2086-2109. 10.1111\/j.1360-0443.2011.03563.x.","journal-title":"Addiction"},{"key":"3800_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pbb.2010.12.012","volume":"98","author":"HM Murphy","year":"2011","unstructured":"Murphy HM, Ihekoronze C, Wideman CH: Zolpidem-induced changes in activity, metabolism, and anxiety in rats. Pharmacol Biochem Behav. 2011, 98: 81-86. 10.1016\/j.pbb.2010.12.012.","journal-title":"Pharmacol Biochem Behav"},{"key":"3800_CR45","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1007\/s00213-014-3473-x","volume":"231","author":"BT Wright","year":"2014","unstructured":"Wright BT, Gluszek CF, Heldt SA: The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: Comparison with diazepam. Psychopharmacology (Berl). 2014, 231: 2967-2979. 10.1007\/s00213-014-3473-x.","journal-title":"Psychopharmacology (Berl)"},{"key":"3800_CR46","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.111.005546","volume":"64","author":"AL Gotter","year":"2012","unstructured":"Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ: International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacology. Pharmacol Rev. 2012, 64: 389-420. 10.1124\/pr.111.005546.","journal-title":"Pharmacol Rev"},{"key":"3800_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/B978-0-444-59489-1.00007-0","volume":"198","author":"SV Mahler","year":"2012","unstructured":"Mahler SV, Smith RJ, Moorman DE, Sartor GC, Ston-Jones G: Multiple roles for orexin\/hypocretin in addiction. Prog Brain Res. 2012, 198: 79-121.","journal-title":"Prog Brain Res"},{"key":"3800_CR48","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1523\/JNEUROSCI.5560-03.2004","volume":"24","author":"CT Beuckmann","year":"2004","unstructured":"Beuckmann CT, Sinton CM, Williams SC, Richardson JA, Hammer RE, Sakurai T, Yanagisawa M: Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci. 2004, 24: 4469-4477. 10.1523\/JNEUROSCI.5560-03.2004.","journal-title":"J Neurosci"},{"key":"3800_CR49","doi-asserted-by":"crossref","first-page":"179ra44","DOI":"10.1126\/scitranslmed.3005213","volume":"5","author":"JM Uslaner","year":"2013","unstructured":"Uslaner JM, Tye SJ, Eddins DM, Wang X, Fox SV, Savitz AT, Binns J, Cannon CE, Garson SL, Yao L, Hodgson R, Stevens J, Bowlby MR, Tannenbaum PL, Brunner J, McDonald TP, Gotter AL, Kuduk SD, Coleman PJ, Winrow CJ, Renger JJ: Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition. Sci Transl Med. 2013, 5: 179ra44.","journal-title":"Sci Transl Med"},{"key":"3800_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1471-2202-14-90","volume":"14","author":"AL Gotter","year":"2013","unstructured":"Gotter AL, Winrow CJ, Brunner J, Garson SL, Fox SV, Binns J, Harrell CM, Cui D, Yee KL, Stiteler M, Stevens J, Savitz A, Tannenbaum PL, Tye SJ, McDonald T, Yao L, Kuduk SD, Uslaner J, Coleman PJ, Renger JJ: The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold. BMC Neurosci. 2013, 14: 90-10.1186\/1471-2202-14-90.","journal-title":"BMC Neurosci"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2202-15-109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:45:08Z","timestamp":1630550708000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/1471-2202-15-109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,22]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3800"],"URL":"https:\/\/doi.org\/10.1186\/1471-2202-15-109","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,22]]},"assertion":[{"value":"11 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"109"}}